Balchem Co. (NASDAQ:BCPC) Shares Purchased by Pictet Asset Management Holding SA

Pictet Asset Management Holding SA grew its stake in shares of Balchem Co. (NASDAQ:BCPC) by 16.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,102 shares of the basic materials company’s stock after buying an additional 703 shares during the quarter. Pictet Asset Management Holding SA’s holdings in Balchem were worth $832,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in the stock. Westside Investment Management Inc. acquired a new stake in Balchem in the third quarter worth approximately $27,000. R Squared Ltd acquired a new stake in shares of Balchem in the fourth quarter valued at $29,000. Wilmington Savings Fund Society FSB bought a new position in Balchem during the third quarter valued at about $35,000. Venturi Wealth Management LLC acquired a new position in Balchem during the fourth quarter worth about $95,000. Finally, Smartleaf Asset Management LLC raised its position in Balchem by 230.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company’s stock worth $106,000 after acquiring an additional 450 shares in the last quarter. 87.91% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on BCPC shares. HC Wainwright reaffirmed a “buy” rating and issued a $190.00 price objective on shares of Balchem in a research note on Monday, February 24th. Sidoti raised Balchem to a “hold” rating in a report on Tuesday, February 25th. Finally, StockNews.com lowered Balchem from a “buy” rating to a “hold” rating in a research note on Tuesday, February 25th.

Balchem Price Performance

BCPC stock opened at $154.13 on Tuesday. Balchem Co. has a one year low of $137.69 and a one year high of $186.03. The firm has a 50-day moving average of $165.30 and a two-hundred day moving average of $168.79. The firm has a market capitalization of $5.01 billion, a PE ratio of 39.22, a P/E/G ratio of 4.41 and a beta of 0.75. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19.

Balchem (NASDAQ:BCPC) last posted its quarterly earnings data on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts’ consensus estimates of $1.11 by ($0.08). The firm had revenue of $240.00 million during the quarter, compared to analyst estimates of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. On average, analysts forecast that Balchem Co. will post 4.64 earnings per share for the current year.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.